Five takeaways on progress altering the Parkinson’s therapeutic landscape, from day two of The Michael J. Fox Foundation’s ...
Neurology residents explore Parkinson's care, research advances and career opportunities at the 2026 MDS-PAS Movement Disorders School.
The U.S. Food and Drug Administration (FDA) has approved tavapadon, a once-daily oral medication for the treatment of motor symptoms of Parkinson’s disease. Tavapadon, which will be sold under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results